Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 5/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24414494 | 1.00 | MAPT (0.47) | MAPTMAPK1TSHRHSD17B10TP53 | |
| SCHEMBL24414506 | 1.00 | MAPT (0.47) | MAPTMAPK1TSHRHSD17B10TP53 | |
| SCHEMBL24414476 | 1.00 | MAPT (0.47) | MAPTMAPK1TSHRHSD17B10TP53 | |
| SCHEMBL24414470 | 1.00 | MAPT (0.47) | MAPTMAPK1TSHRHSD17B10TP53 | |
| SCHEMBL24414542 | 1.00 | MAPT (0.47) | MAPTMAPK1TSHRHSD17B10TP53 | |
| SCHEMBL4733112 | 0.84 | MAPT (0.40) | MAPTMAPK1TSHRHSD17B10TP53 | |
| SCHEMBL536618 | 0.84 | TDP1 (0.48) | MAPTMAPK1TSHRHSD17B10TP53 | |
| SCHEMBL6215006 | 0.83 | TSHR (0.50) | MAPTMAPK1TSHRHSD17B10TP53 | |
| SCHEMBL767015 | 0.83 | TSHR (0.50) | MAPTMAPK1TSHRHSD17B10TP53 | |
| SCHEMBL1498188 | 0.83 | MAPT (0.47) | MAPTMAPK1TSHRHSD17B10TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 476 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12338197-B2 | Process for preparation of amides and esters of 2-((2-hydroxypropanoyl)oxy)propanoic acid | UNIVERZITA PARDUBICE (CZ) | 2025-06-24 | — | — | US | claimed |
| EP-4361238-A1 | COMPOSITIONS COMPRISING GLYCAMINES | ChemTEK UG (haftungsbeschränkt) (DE) | 2024-05-01 | — | — | EP | claimed |
| US-20230118459-A1 | ANTIVIRAL TREATMENT | ECOSYNTH NV (BE) | 2023-04-20 | — | — | US | claimed |
| EP-4114376-A1 | ANTIVIRAL TREATMENT | Ecosynth (BE) | 2023-01-11 | — | — | EP | claimed |
| US-20220041542-A1 | A process for preparation of amides and esters of 2-((2-hydroxypropanoyl)oxy)propanoic acid | UNIVERZITA PARDUBICE (CZ) | 2022-02-10 | — | — | US | claimed |
| EP-3898570-A1 | A PROCESS FOR PREPARATION OF AMIDES AND ESTHERS OF 2-((2-HYDROXYPANOYL)OXY)PROPANOIC ACID | Univerzita Pardubice (CZ) | 2021-10-27 | — | — | EP | claimed |
| CN-105030555-B | Surfactant compositions and high oil content formulations containing the same | 赢创运营有限公司 | 2021-10-15 | — | — | CN | claimed |
| WO-2021176010-A1 | ANTIVIRAL TREATMENT | ECOSYNTH NV (BE) | 2021-09-10 | — | — | WO | claimed |
| CN-111920725-A | Children shampoo and shower gel containing organic acid mild preservative and preparation method thereof | 福建省梦娇兰日用化学品有限公司 | 2020-11-13 | — | — | CN | claimed |
| WO-2020125823-A1 | A PROCESS FOR PREPARATION OF AMIDES AND ESTHERS OF 2-((2-HYDROXYPANOYL)OXY)PROPANOIC ACID | UNIVERZITA PARDUBICE (CZ) | 2020-06-25 | — | — | WO | claimed |
| US-20020197185-A1 | ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES | ETHICON, INC. | 2002-12-26 | — | — | US | claimed |
| EP-1009398-A1 | MOLECULAR COMPLEX AND CONTROL-RELEASE OF ALPHA HYDROXYACIDS | Yu, Ruey J., Dr. (US) | 2000-06-21 | — | — | EP | claimed |
| US-5886041-A | SKIN DISORDERS | TRISTRATA TECHNOLOGY, INC. (US) | 1999-03-23 | — | — | US | claimed |
| US-5877212-A | HYDROGEN BONDING WITH COMPLEXING AGENT | YU RUEY J (US) | 1999-03-02 | — | — | US | claimed |
| WO-1998046217-A1 | MOLECULAR COMPLEX AND CONTROL-RELEASE OF ALPHA HYDROXYACIDS | YU RUEY J (US) | 1998-10-22 | — | — | WO | claimed |
| US-5811112-A | LEAVE-ON SKIN CARE PRODUCT; TREATMENT OF DRYNESS, WRINKLING | CHESEBROUGH-POND'S USA CO., DIVISION OF CONOPCO INC. (US) | 1998-09-22 | — | — | US | claimed |
| EP-0413528-B1 | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use | YU RUEY J (US) | 1995-11-15 | — | — | EP | claimed |
| EP-0671162-A2 | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use | Yu, Ruey J., Dr. (US) | 1995-09-13 | — | — | EP | claimed |
| US-5091171-A | Skin disorders | IGI, INC. | 1992-02-25 | — | — | US | claimed |
| EP-0413528-A1 | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use | Yu, Ruey J., Dr. (US) | 1991-02-20 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230118459-A1 | ANTIVIRAL TREATMENT | MAVS, ACE, ACE2 | MAPT 2171/4885MAPK1 4086/4885TSHR 4316/4885 |
| US-20220041542-A1 | A process for preparation of amides and esters of 2-((2-hydroxypropanoyl)oxy)propanoic acid | ADH1C, ADH1A, ADH5 | MAPT 3867/4885MAPK1 2888/4885TSHR 540/4885 |
| US-12338197-B2 | Process for preparation of amides and esters of 2-((2-hydroxypropanoyl)oxy)propanoic acid | HRH2, LDHA, HCAR2 | MAPT 3861/4885MAPK1 2557/4885TSHR 69/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.